In LMICs, the availability of medicines manufactured locally that do not meet quality standards is a leading cause of treatment failure and adverse events in patients and is undermining public health interventions. But where do things go wrong during pharmaceutical manufacturing in LMICs that give rise to this problem? Learn more.
Particulate matter in injectable drug products have been the reason for many recent drug recalls. In this blog post, Desmond Hunt, Ph.D., discusses sources of particulate matter and how to control them in the manufacturing process.
With the debate about the safety of food additives recently revived in the media, proper identification of the additives themselves is an aspect of food safety often forgotten. It is assumed food ingredients are well known before safety assessments are performed, but that might not be always true.